UPCOMING SESSIONS in ET

Thu, Jul 30, 2026

5:00 – 6:00 AM Bangkok

Stem Cell Transplant for AL Amyloidosis: Who Should Receive It and When Tibor Kovacsovics Click Here To Register

UPCOMING SESSIONS in ET

Thu, Jul 30, 2026 · 5:00 – 6:00 AM Bangkok

Stem Cell Transplant for AL Amyloidosis: Who Should Receive It and When

Tibor Kovacsovics

Click Here To Register

View all sessions

themendedhearts

Published: Jul 28, 2026

Category

Source

https://www.instagram.com/p/DbT4XE9jEBn/

Details

The TRITON-CM study is exploring an investigational medication for people living with ATTR amyloidosis to see if it could lower their number of urgent heart-related events.

Visit TRITONstudies.com to learn more.
#ClinicalTrials #MedicalResearch

Newsletter

RNAi Explained

Dr. Bersell explores RNA interference (RNAi) technology and its applications in treating ATTR-CM and ATTR-PN. Learn about mechanism of action, clinical evidence, and patient outcomes.

Expert Perspectives on Attruby®

Dr. Barry Trachtenberg and ATTR community members discuss Attruby™ (acoramidis), covering clinical data, patient perspectives, and treatment considerations.

Watch Discussion

Featured Trials